Loading...

Clinical Practice Guidelines

Hepatitis E Virus Infection EASL Guideline

  • Adonia DHANJAL
Hepatitis E Virus Infection (HEV) is a significant cause of morbidity and mortality, representing an important global health problem. Our understanding of HEV has changed completely over the past decade. Previously, the common thought was that HEV was limited to certain developing countries. We now know that HEV is endemic in most high-income countries and is largely a zoonotic infection. The focus of this Clinical Practice Guideline will be on HEV genotype 3 (and 4). This is due to the paradigm shift in our understanding of zoonotic HEV.  And also because locally acquired HEV is now the commonest cause of acute viral hepatitis in many European countries.
Read more

Management of Decompensated Cirrhosis EASL Guideline

EASL Guideline on Management of Decompensated Cirrhosis. The natural history of cirrhosis is characterized by an asymptomatic compensated phase followed by a decompensated phase, marked by the development of overt clinical signs, the most frequent of which are ascites, bleeding, encephalopathy, and jaundice. The following Clinical Practice Guidelines (CPGs) represent the first Guideline on the Management of Decompensated Cirrhosis.
Read more

Management of Alcohol-Related Liver Disease

  • Adonia DHANJAL
The harmful use of alcohol has been estimated to cause approximately 3.3 million deaths every year. Most importantly, this corresponds to nearly 6% of all deaths globally. Therefore, the effective treatment and Management of Alcohol-Related Liver Disease is a pertinent public health issue.  In conclusion, the following  EASL Clinical Practice Guideline reviews and provides the latest data on the treatment and Management of Alcohol-Related Liver Disease and updates recommendations for clinical management.
Read more

Hepatitis B EASL Guidelines

EASL Guideline on Hepatitis B. Hepatitis B virus (HBV) infection remains a global public health problem with changing epidemiology due to several factors including vaccination policies and migration. This EASL Clinical Practice Guideline presents updated recommendations for the optimal management of HBV infection. Chronic HBV infection can be classified into five phases: (I) HBeAg-positive chronic infection, (II) HBeAg-positive chronic hepatitis, (III) HBeAg-negative chronic infection, (IV) HBeAg-negative chronic hepatitis and (V) HBsAg-negative phase.
Read more

Role of Endoscopy in Primary Sclerosing Cholangitis

This guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE) and of the European Association for the Study of the Liver (EASL) on primary sclerosing cholangitis. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence.
Read more

Acute Liver Failure Guidelines

The term acute liver failure (ALF) is frequently applied as a generic expression to describe patients presenting with or developing an acute episode of liver dysfunction. In the context of hepatological practice, however, ALF refers to a highly specific and rare syndrome. This means an acute abnormality of liver blood tests in an individual without underlying chronic liver disease. The disease process is associated with development of a coagulopathy of liver aetiology, and clinically apparent altered level of consciousness due to hepatic encephalopathy. Several important measures are immediately necessary when the patient presents for medical attention. These, as well as additional clinical procedures will be the subject of the Acute Liver Failure Guidelines.
Read more

Primary Biliary Cholangitis EASL Guideline

Primary biliary cholangitis (PBC) is a chronic inflammatory autoimmune cholestatic liver disease, which when untreated will culminate in end-stage biliary cirrhosis. Diagnosis is usually based on the presence of serum liver tests indicative of a cholestatic hepatitis in association with circulating antimitochondrial antibodies. Patient presentation and course can be diverse and risk stratification is important to ensure all patients receive a personalised approach to their care.
Read more

EASL Recommendations on Treatment of Hepatitis C (2016)

Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. The long-term impact of HCV infection is highly variable, ranging from minimal histological changes to extensive fibrosis and cirrhosis with or without hepatocellular carcinoma (HCC). The number of chronically infected persons worldwide is estimated to be about 180 million,…
Read more

Management of benign liver tumours

Benign liver tumours are a heterogeneous group of lesions with different cellular origins, as summarized by an international panel of experts sponsored by the World Congress of Gastroenterology in 1994. These lesions are frequently found incidentally as a consequence of the widespread use of imaging tests and often have a benign course. Some of these…
Read more

Prevention, diagnosis and treatment of gallstones

Gallstones or cholelithiasis are a major public health problem in Europe and other developed countries and affect up to 20% of the population. Gallstone disease is the most common gastrointestinal disorder for which patients are admitted to hospitals in European countries. The interdisciplinary care for patients with gallstone disease has advanced considerably during recent decades…
Read more
Share
Back To Top